Search

Your search keyword '"Shiina, Hiroaki"' showing total 747 results
Start Over Author "Shiina, Hiroaki"
747 results on '"Shiina, Hiroaki"'

1. Site-specific Risk Stratification Models for Postoperative Recurrence and Survival Prediction in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: Better Stratification for Adjuvant Therapy

Author

Miyake, Makito, Iida, Kota, Nishimura, Nobutaka, Inoue, Takashi, Matsumoto, Hiroaki, Matsuyama, Hideyasu, Fujiwara, Yuya, Komura, Kazumasa, Inamoto, Teruo, Azuma, Haruhito, Yasumoto, Hiroaki, Shiina, Hiroaki, Yonemori, Masaya, Enokida, Hideki, Nakagawa, Masayuki, Fukuhara, Hideo, Inoue, Keiji, Yoshida, Takashi, Kinoshita, Hidefumi, Matsuda, Tadashi, Fujii, Tomomi, and Fujimoto, Kiyohide

Published
2022
Full Text
View/download PDF

4. Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment

Author

Minami, Keita, Osawa, Takahiro, Kojima, Takahiro, Hara, Tomohiko, Eto, Masatoshi, Takeuchi, Ario, Nakai, Yasutomo, Ueda, Kosuke, Ozawa, Michinobu, Uemura, Motohide, Ohba, Kojiro, Tamura, Keita, Shindo, Tetsuya, Nakagomi, Hiroshi, Takahashi, Atsushi, Anai, Satoshi, Yokomizo, Akira, Morizane, Shuichi, Kimura, Takahiro, Shimazui, Toru, Miyauchi, Yasuyuki, Mitsuzuka, Koji, Hara, Hiroaki, Yoshimura, Koji, Shiina, Hiroaki, Ito, Youichi M, Murai, Sachiyo, Nishiyama, Hiroyuki, Shinohara, Nobuo, and Kitamura, Hiroshi

Published
2023
Full Text
View/download PDF

5. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

Author

Park, Se Hoon, van der Heijden, Michiel S., Necchi, Andrea, Castellano, Daniel, Bamias, Aristotelis, Lee, Jae Lyun, De Giorgi, Ugo, Bögemann, Martin, Eigl, Bernhard J., Tsiatas, Marinos, Powles, Thomas, Novikov, Andrey, Skoneczna, Iwona, Mukherjee, Som D., Suarez, Cristina, Westgeest, Hans, Fradet, Yves, Flechon, Aude, Ou, Yen-Chuan, Park, Inkeun, Matveev, Vsevolod, Pérez-Valderrama, Begoña, Cheng, Susanna, Frank, Stephen, Gurney, Howard, Anido, Urbano, Hamzaj, Alketa, Retz, Margitta, Sridhar, Srikala, Scagliotti, Giorgio Vittorio, Voortman, Jens, Alekseev, Boris, Alyasova, Anna, Komyakov, Boris, Dumez, Herlinde, Pavic, Michel, Kimura, Go, Mizokami, Atsushi, Osanto, Susanne, Arranz, Jose Angel, Piersma, Djura, Shin, Sang Joon, Karyakin, Oleg, Delgado, Ignacio, Gonzalez, Jose Luis, Pang, See-Tong, Tran, Anna, Lipatov, Oleg, Su, Wen-Pin, Flaig, Thomas, Alva, Ajjai, Park Kyong, Hwa, Kopyltsov, Evgeny, Almagro, Elena, Domenech, Monserrat, Chang, Yen-Hwa, Sautois, Brieuc, Ravaux, Andre, Aravantinos, Gerasimos, Georgoulias, Vasileios, Mulder, Sasja, Kim, Yu Jung, Kater, Fabio, Chevreau, Christine, Tagawa, Scott, Zalewski, Pawel, Joly, Florence, Loriot, Yohann, Hatiboglu, Gencay, Gianni, Luca, Morelli, Franco, Tambaro, Rosa, Hashimoto, Yasuhiro, Nosov, Alexander, Font, Albert, Rodriguez-Vida, Alejo M., Jones, Robert, Vasudev, Naveen, Srinivas, Sandhya, Zhang, Jingsong, Gil, Thierry, Finch, Daygen, Grimm, Marc-Oliver, Su, Yu-Li, Chowdhury, Simon, Hocking, Christopher, Plas, Eugen, North, Scott, Jensen, Niels Viggo, Theodore, Christine, Imkamp, Florian, Peer, Avivit, Kobayashi, Takashi, Sakai, Hideki, Sassa, Naoto, Yoshimura, Kazuhiro, Aarts, Maureen, Ferreira Castro, Ana, Topuzov, Marlen, Rodriguez, Juan Francisco, Vazquez, Federico Jose, Tsai, Yu-Chieh, Crabb, Simon, Hussain, Syed, Bendell, Johanna, Gross-Goupil, Marine, Gwenaelle, Gravis, Berger, Raanan, Statsenko, Galina, Evans, Linda, Drakaki, Alexandra, Somer, Bradley, Davis, Ian, Lynam, James, Borges, Giuliano, Dettino, Aldo, Fay, André P., Martins, Graziella, Zucca, Luis Eduardo, Agerbaek, Mads, Kalofonos, Haralambos, Rosenbaum, Eli, Enokida, Hideki, Kikukawa, Hiroaki, Nishimura, Kazuo, Tamada, Satoshi, Uemura, Motohide, Lopez, Yamil, Gietema, Jourik, Slojewski, Marcin, Fernandes, Isabel, Smolin, Alexey, Mazhar, Danish, Kalebasty, Arash Rezazadeh, Carthon, Bradley, Loidl, Wolfgang, Franke, Fabio, Girotto, Gustavo, Alimohamed, Nimira, Macfarlane, Robyn, Pappot, Helle, Niegisch, Guenter, Mavroudis, Dimitrios, Sella, Avishay, Porta, Camillo, Ebara, Shin, Nakamura, Motonobu, Obara, Wataru, Okuno, Norihiko, Shinohara, Nobuo, Sugimoto, Mikio, Suzuki, Akitaka, Tokuda, Noriaki, Uemura, Hiroji, Yamaguchi, Akito, Ramirez, Francisco, Rozanowski, Pawel, Wiechno, Pawel, Keam, Bhumsuk, Kislov, Nikolay, Plaksin, Denis, Cicin, Irfan, Kumar, Satish, Galsky, Matthew D., Petrylak, Daniel P., Rosales, Joseph, Vaishampayan, Ulka, Culine, Stephane, Papandreou, Christos, Nara, Taketoshi, Erman, Mustafa, Kreiger, Laurence, Janoski, Juliana, Rosa, Diogo, Siqueira, Mariana, Canil, Christina, Sengelov, Lisa, Tourani, Jean-Marc, Arai, Gaku, Hashine, Katsuyoshi, Kawakita, Mutsushi, Nakaigawa, Noboru, Nomi, Hayahito, Shiina, Hiroaki, Suzuki, Hiroyoshi, Yonese, Junji, Kuri, Roberto, Macedo, Eleazar, Rivera, Samuel, Villalobos Prieto, Alberto, Polakiewicz-Gilowska, Anna, Zaucha, Renata, Lopes, Fabio, Ponomarev, Roman, Pomerantz, Mark, Shariat, Shahrokh, Luk, Cynthia, Lesniewski-Kmak, Krzysztof, van der Heijden, Michiel S, Galsky, Matthew D, Petrylak, Daniel P, Ogawa, Osamu, Lee, Jae-Lyun, Eigl, Bernhard J, Mukherjee, Som D, Suárez, Cristina, Fay, André P, Duran, Ignacio, Wildsmith, Sophie, He, Philip, Angra, Natasha, Gupta, Ashok K, Levin, Wendy, and Bellmunt, Joaquim

Published
2020
Full Text
View/download PDF

6. Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancer

Author

Mitsui, Yozo, Chang, Inik, Kato, Taku, Hashimoto, Yutaka, Yamamura, Soichiro, Fukuhara, Shinichiro, Wong, Darryn K, Shiina, Marisa, Imai-Sumida, Mitsuho, Majid, Shahana, Saini, Sharanjot, Shiina, Hiroaki, Nakajima, Koichi, Deng, Guoren, Dahiya, Rajvir, and Tanaka, Yuichiro

Subjects
Aging, Prevention, Tobacco Smoke and Health, Prostate Cancer, Tobacco, Biotechnology, Cancer, Urologic Diseases, Genetics, 2.1 Biological and endogenous factors, Aetiology, Aged, Aged, 80 and over, Apoptosis, Azacitidine, Cell Line, Tumor, CpG Islands, Cytochrome P-450 CYP1A1, DNA Methylation, Decitabine, Enhancer Elements, Genetic, Epigenesis, Genetic, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Humans, Male, Middle Aged, Oligonucleotide Array Sequence Analysis, Polymerase Chain Reaction, Promoter Regions, Genetic, Prostatic Hyperplasia, Prostatic Neoplasms, Sulfites, Tissue Array Analysis, Tobacco Smoking, Xenobiotics, cytochrome P450 1A1, methylation, prostate cancer, tobacco smoking, Oncology and Carcinogenesis
Abstract

Cytochrome P450 (CYP) 1A1 is a phase I enzyme that can activate various compounds into reactive forms and thus, may contribute to carcinogenesis. In this study, we investigated the expression, methylation status, and functional role of CYP1A1 on prostate cancer cells. Increased expression of CYP1A1 was observed in all cancer lines (PC-3, LNCaP, and DU145) compared to BPH-1 (P < 0.05); and was enhanced further by 5-aza-2'-deoxycytidine treatment (P < 0.01). Methylation-specific PCR (MSP) and sequencing of bisulfite-modified DNA of the xenobiotic response element (XRE) enhancer site XRE-1383 indicated promoter methylation as a regulator of CYP1A1 expression. In tissue, microarrays showed higher immunostaining of CYP1A1 in prostate cancer than normal and benign prostatic hyperplasia (BPH; P < 0.001), and methylation analyses in clinical specimens revealed significantly lower methylation levels in cancer compared to BPH at all enhancer sites analyzed (XRE-1383, XRE-983, XRE-895; P < 0.01). Interestingly, smoking affected the XRE-1383 site where the methylation level was much lower in cancer tissues from smokers than non-smokers (P < 0.05). CYP1A1 levels are thus increased in prostate cancer and to determine the functional effect of CYP1A1 on cells, we depleted the gene in LNCaP and DU145 by siRNA. We observe that CYP1A1 knockdown decreased cell proliferation (P < 0.05) and increased apoptosis (P < 0.01) in both cell lines. We analyzed genes affected by CYP1A1 silencing and found that apoptosis-related BCL2 was significantly down-regulated. This study supports an oncogenic role for CYP1A1 in prostate cancer via promoter hypomethylation that is influenced by tobacco smoking, indicating CYP1A1 to be a promising target for prostate cancer treatment.

Published
2016

7. CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma

Author

Mitsui, Yozo, Chang, Inik, Fukuhara, Shinichiro, Hiraki, Miho, Arichi, Naoko, Yasumoto, Hiroaki, Hirata, Hiroshi, Yamamura, Soichiro, Shahryari, Varahram, Deng, Guoren, Wong, Darryn K, Majid, Shahana, Shiina, Hiroaki, Dahiya, Rajvir, and Tanaka, Yuichiro

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Rare Diseases, Genetics, Biotechnology, Kidney Disease, Cancer, 2.1 Biological and endogenous factors, Aetiology, Apoptosis, Carcinoma, Renal Cell, Cdc20 Proteins, Cell Line, Tumor, Cell Movement, Cytochrome P-450 CYP1B1, Death-Associated Protein Kinases, Female, Gene Expression Regulation, Neoplastic, Humans, Kidney Neoplasms, Male, Middle Aged, Neoplasm Invasiveness, Up-Regulation, Cytochrome 450 1B1, Renal cell carcinoma, CDC20, DAPK1, Public Health and Health Services, Oncology & Carcinogenesis, Oncology and carcinogenesis, Epidemiology
Abstract

BackgroundCytochrome P450 1B1 (CYP1B1) has been shown to be up-regulated in many types of cancer including renal cell carcinoma (RCC). Several reports have shown that CYP1B1 can influence the regulation of tumor development; however, its role in RCC has not been well investigated. The aim of the present study was to determine the functional effects of CYP1B1 gene on tumorigenesis in RCC.MethodsExpression of CYP1B1 was determined in RCC cell lines, and tissue microarrays of 96 RCC and 25 normal tissues. To determine the biological significance of CYP1B1 in RCC progression, we silenced the gene in Caki-1 and 769-P cells by RNA interference and performed various functional analyses.ResultsFirst, we confirmed that CYP1B1 protein expression was significantly higher in RCC cell lines compared to normal kidney tissue. This trend was also observed in RCC samples (p

Published
2015

10. The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA)

Author

Inoue, Keiji, Matsuyama, Hideyasu, Fujimoto, Kiyohide, Hirao, Yoshihiko, Watanabe, Hironobu, Ozono, Seiichiro, Oyama, Masafumi, Ueno, Munehisa, Sugimura, Yoshiki, Shiina, Hiroaki, Mimata, Hiromitsu, Azuma, Haruhito, Nagase, Yasushi, Matsubara, Akio, Ito, Yoichi M, and Shuin, Taro

Published
2016
Full Text
View/download PDF

13. A Case of Significant Fibrosis in Irradiation Field After Salvage Radiation Therapy for Postprostatectomy Biochemical Recurrence

Author

UE, Atsushi, YAMAGISHI, Mutsumi, UNO, Masafumi, NAGANO, Natsuko, Hieda, Yoko, NAGAMI, Taichi, Shiina, Hiroaki, and Tamaki, Yukihisa

Subjects
prostatespecific antigen recurrence, postoperative, salvage radiotherapy, prostate cancer
Abstract

An 80-year-old man received salvage radiation therapy for prostate-specific antigen recurrence of prostate cancer after prostatectomy. Urinary retention and edema of both legs developed 1 year and 3 months after initiation of radiation therapy. Imaging showed significant fibrosis in the radiation field. Histological findings were characteristic of ischemic changes, but not retroperitoneal fibrosis or fibrosarcoma. Development of significant fibrosis with accompanying symptoms after postoperative radiation therapy is rare in prostate cancer. The patient’s history of heavy smoking and arteriosclerotic diseases ( e.g., cerebral infarction and carotid artery stenosis ), in addition to an elevated D-dimer level confirmed by blood test, suggested the presence of underlying advanced vascular endothelial disorders and microvascular circulatory disorders. Significant fibrosis was likely caused by the patient’s underlying condition in addition to surgery and extensive radiation to the pelvis.

Published
2021

14. Efficacy of Androgen Receptor-targeted Drugs After Prostate Cancer Recurrence With Bone Metastases: PROSTAT-BSI Sub-analysis

Author

KAMIJIMA, TAIKI, primary, YAEGASHI, HIROSHI, additional, MIZOKAMI, ATSUSHI, additional, NAKAJIMA, KENICHI, additional, MATSUYAMA, HIDEYASU, additional, ICHIKAWA, TOMOHIKO, additional, NISHIMOTO, KOSHIRO, additional, TAKAHASHI, SATORU, additional, SHIINA, HIROAKI, additional, HORIKOSHI, HIROYUKI, additional, HASHINE, KATSUYOSHI, additional, SUGIYAMA, YUTAKA, additional, MIYAO, TAKESHI, additional, KAMIYAMA, MANABU, additional, HARADA, KENICHI, additional, ITO, AKITO, additional, and ENOKIDA, HIDEKI, additional

Published
2022
Full Text
View/download PDF

15. Efficacy of New Therapies for Relapse After Docetaxel Treatment of Bone Metastatic Castration-resistant Prostate Cancer in Clinical Practice

Author

MIZOKAMI, ATSUSHI, primary, NISHIMOTO, KOSHIRO, additional, MATSUYAMA, HIDEYASU, additional, ICHIKAWA, TOMOHIKO, additional, TAKAHASHI, SATORU, additional, SHIINA, HIROAKI, additional, HASHINE, KATSUYOSHI, additional, SUGIYAMA, YUTAKA, additional, KAMIYAMA, MANABU, additional, ENOKIDA, HIDEKI, additional, and NAKAJIMA, KENICHI, additional

Published
2022
Full Text
View/download PDF

16. The Simultaneous Onset of Pancreatitis and Colitis as Immune-related Adverse Events in a Patient Receiving Nivolumab Treatment for Renal Cell Carcinoma

Author

Yazaki, Tomotaka, primary, Moriyama, Ichiro, additional, Tobita, Hiroshi, additional, Sonoyama, Hiroki, additional, Okimoto, Eiko, additional, Oka, Akihiko, additional, Mishima, Yoshiyuki, additional, Oshima, Naoki, additional, Shibagaki, Kotaro, additional, Kawashima, Kousaku, additional, Ishimura, Norihisa, additional, Nagami, Taichi, additional, Maruyama, Riruke, additional, Shiina, Hiroaki, additional, and Ishihara, Shunji, additional

Published
2022
Full Text
View/download PDF

17. Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men

Author

Chang, Inik, Fukuhara, Shinichiro, Wong, Darryn K., Gill, Ankurpreet, Mitsui, Yozo, Majid, Shahana, Saini, Sharanjot, Yamamura, Soichiro, Chiyomaru, Takeshi, Hirata, Hiroshi, Ueno, Koji, Arora, Sumit, Shahryari, Varahram, Deng, Guoren, Tabatabai, Z. Laura, Greene, Kirsten L., Shin, Dong Min, Enokida, Hideki, Shiina, Hiroaki, Nonomura, Norio, Dahiya, Rajvir, and Tanaka, Yuichiro

Published
2014
Full Text
View/download PDF

24. Predictive factors for the effectiveness of novel androgen receptor axis‐targeted agents in patients with metastatic prostate cancer.

Author

Koshiro, Nishimoto, Nakajima, Kenichi, Oyama, Masafumi, Kaneko, Go, Takahashi, Satoru, Matsuyama, Hideyasu, Shiina, Hiroaki, Ichikawa, Tomohiko, Horikoshi, Hiroyuki, Hashine, Katsuyoshi, Sugiyama, Yutaka, Miyao, Takeshi, Kamiyama, Manabu, Harada, Kenichi, Ito, Akito, and Mizokami, Atsushi

Subjects
ANDROGEN receptors, PROSTATE cancer patients, CASTRATION-resistant prostate cancer, BONE metastasis, RADIONUCLIDE imaging
Abstract

Objective: Novel androgen receptor axis‐targeted agents (ARATAs) have been developed for mCRPC and improved overall survival (OS). Here, we aimed to find predictors who will receive the greatest benefits from ARATAs. Methods: We previously performed a multicenter study to identify prognostic factors for metastatic hormone‐sensitive prostate cancer (mHSPC, n = 148) and mCRPC (n = 99), and showed that the bone scan index (BSI) was one of the significant prognostic factors for 3‐year OS (PROSTAT‐BSI study). mHSPC progressed to mCRPC (n = 101), for which 69 patients were treated with (n = 39) or without ARATAs (n = 30, prior to the approval of ARATAs). The 69 patients were divided into two groups according to patient factors, and these cohorts were further divided into two subgroups by usage of ARATAs. OS was compared between subgroups in each group. Results: The predictors were age (<71.4 years), serum levels of C‐reactive protein (≥0.16 ng/ml) and alkaline phosphatase (≥548 U/L), time to PSA progression after ADT (<8.9 months), the lowest PSA level (≥1 ng/ml) after ADT, and the rate of PSA decline 3 months after ADT (<0.987), whereas hemoglobin levels, PSA before ADT, Gleason scores, existence of visceral metastases, and BSI were not. Conclusions: The present study identified predictors for the effectiveness of ARATAs. The number of bone metastases (≒BSI), existence of visceral metastases, and Gleason scores, which were identified as high‐risk factors in the LATITUDE study and disease volume in CHAARTED criteria, did not appear to be useful for predicting effectiveness from ARATAs. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

40. Development and external validation of a preoperative nomogram for predicting pathological locally advanced disease of clinically localized upper urinary tract carcinoma

Author

Yoshida, Takashi, Kobayashi, Takashi, Kawaura, Takayuki, Miyake, Makito, Ito, Katsuhiro, Okuno, Hiroshi, Murota, Takashi, Makita, Noriyuki, Kawakita, Mutsushi, Kawa, Gen, Kitawaki, Tomoki, Fujimoto, Kiyohide, Matsuyama, Hideyasu, Shiina, Hiroaki, Azuma, Haruhito, Ogawa, Osamu, Kinoshita , Hidefumi, Matsuda, Tadashi, Yoshida, Takashi, Kobayashi, Takashi, Kawaura, Takayuki, Miyake, Makito, Ito, Katsuhiro, Okuno, Hiroshi, Murota, Takashi, Makita, Noriyuki, Kawakita, Mutsushi, Kawa, Gen, Kitawaki, Tomoki, Fujimoto, Kiyohide, Matsuyama, Hideyasu, Shiina, Hiroaki, Azuma, Haruhito, Ogawa, Osamu, Kinoshita , Hidefumi, and Matsuda, Tadashi

Published
2020

43. Efficacy of holmium laser enucleation in patients with a small (less than 30 mL) prostate volume

Author

Tsuboi, Ichiro, primary, Maruyama, Yuki, additional, Sadahira, Takuya, additional, Ando, Nobuyoshi, additional, Nishiyama, Yasuhiro, additional, Araki, Motoo, additional, Kurashige, Takushi, additional, Ichikawa, Takaharu, additional, Arata, Ryoji, additional, Ono, Noriaki, additional, Watanabe, Toyohiko, additional, Hayata, Syunji, additional, Shiina, Hiroaki, additional, and Nasu, Yasutomo, additional

Published
2021
Full Text
View/download PDF

45. Tumor Location Based Segmentation in Upper-Tract Urothelial Carcinoma Impacts on the Urothelial Recurrence-Free Survival: A Multi-Institutional Database Study

Author

Inamoto, Teruo, primary, Matsuyama, Hideyasu, additional, Komura, Kazumasa, additional, Ibuki, Naokazu, additional, Fujimoto, Kiyohide, additional, Shiina, Hiroaki, additional, Sakano, Shigeru, additional, Nagao, Kazuhiro, additional, Mastumoto, Hiroaki, additional, Miyake, Makito, additional, Tatsumi, Yoshihiro, additional, Yasumoto, Hiroaki, additional, and Azuma, Haruhito, additional

Published
2020
Full Text
View/download PDF

46. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

Author

Powles, Thomas, primary, van der Heijden, Michiel S, additional, Castellano, Daniel, additional, Galsky, Matthew D, additional, Loriot, Yohann, additional, Petrylak, Daniel P, additional, Ogawa, Osamu, additional, Park, Se Hoon, additional, Lee, Jae-Lyun, additional, De Giorgi, Ugo, additional, Bögemann, Martin, additional, Bamias, Aristotelis, additional, Eigl, Bernhard J, additional, Gurney, Howard, additional, Mukherjee, Som D, additional, Fradet, Yves, additional, Skoneczna, Iwona, additional, Tsiatas, Marinos, additional, Novikov, Andrey, additional, Suárez, Cristina, additional, Fay, André P, additional, Duran, Ignacio, additional, Necchi, Andrea, additional, Wildsmith, Sophie, additional, He, Philip, additional, Angra, Natasha, additional, Gupta, Ashok K, additional, Levin, Wendy, additional, Bellmunt, Joaquim, additional, van der Heijden, Michiel S., additional, Lee, Jae Lyun, additional, Eigl, Bernhard J., additional, Powles, Thomas, additional, Mukherjee, Som D., additional, Suarez, Cristina, additional, Westgeest, Hans, additional, Flechon, Aude, additional, Ou, Yen-Chuan, additional, Park, Inkeun, additional, Matveev, Vsevolod, additional, Pérez-Valderrama, Begoña, additional, Cheng, Susanna, additional, Frank, Stephen, additional, Anido, Urbano, additional, Hamzaj, Alketa, additional, Retz, Margitta, additional, Sridhar, Srikala, additional, Scagliotti, Giorgio Vittorio, additional, Voortman, Jens, additional, Alekseev, Boris, additional, Alyasova, Anna, additional, Komyakov, Boris, additional, Dumez, Herlinde, additional, Pavic, Michel, additional, Kimura, Go, additional, Mizokami, Atsushi, additional, Osanto, Susanne, additional, Arranz, Jose Angel, additional, Piersma, Djura, additional, Shin, Sang Joon, additional, Karyakin, Oleg, additional, Delgado, Ignacio, additional, Gonzalez, Jose Luis, additional, Pang, See-Tong, additional, Tran, Anna, additional, Lipatov, Oleg, additional, Su, Wen-Pin, additional, Flaig, Thomas, additional, Alva, Ajjai, additional, Park Kyong, Hwa, additional, Kopyltsov, Evgeny, additional, Almagro, Elena, additional, Domenech, Monserrat, additional, Chang, Yen-Hwa, additional, Sautois, Brieuc, additional, Ravaux, Andre, additional, Aravantinos, Gerasimos, additional, Georgoulias, Vasileios, additional, Mulder, Sasja, additional, Kim, Yu Jung, additional, Kater, Fabio, additional, Chevreau, Christine, additional, Tagawa, Scott, additional, Zalewski, Pawel, additional, Joly, Florence, additional, Hatiboglu, Gencay, additional, Gianni, Luca, additional, Morelli, Franco, additional, Tambaro, Rosa, additional, Hashimoto, Yasuhiro, additional, Nosov, Alexander, additional, Font, Albert, additional, Rodriguez-Vida, Alejo M., additional, Jones, Robert, additional, Vasudev, Naveen, additional, Srinivas, Sandhya, additional, Zhang, Jingsong, additional, Gil, Thierry, additional, Finch, Daygen, additional, Grimm, Marc-Oliver, additional, Su, Yu-Li, additional, Chowdhury, Simon, additional, Hocking, Christopher, additional, Plas, Eugen, additional, North, Scott, additional, Jensen, Niels Viggo, additional, Theodore, Christine, additional, Imkamp, Florian, additional, Peer, Avivit, additional, Kobayashi, Takashi, additional, Sakai, Hideki, additional, Sassa, Naoto, additional, Yoshimura, Kazuhiro, additional, Aarts, Maureen, additional, Ferreira Castro, Ana, additional, Topuzov, Marlen, additional, Rodriguez, Juan Francisco, additional, Vazquez, Federico Jose, additional, Tsai, Yu-Chieh, additional, Crabb, Simon, additional, Hussain, Syed, additional, Bendell, Johanna, additional, Gross-Goupil, Marine, additional, Gwenaelle, Gravis, additional, Berger, Raanan, additional, Statsenko, Galina, additional, Evans, Linda, additional, Drakaki, Alexandra, additional, Somer, Bradley, additional, Davis, Ian, additional, Lynam, James, additional, Borges, Giuliano, additional, Dettino, Aldo, additional, Fay, André P., additional, Martins, Graziella, additional, Zucca, Luis Eduardo, additional, Agerbaek, Mads, additional, Kalofonos, Haralambos, additional, Rosenbaum, Eli, additional, Enokida, Hideki, additional, Kikukawa, Hiroaki, additional, Nishimura, Kazuo, additional, Tamada, Satoshi, additional, Uemura, Motohide, additional, Lopez, Yamil, additional, Gietema, Jourik, additional, Slojewski, Marcin, additional, Fernandes, Isabel, additional, Smolin, Alexey, additional, Mazhar, Danish, additional, Kalebasty, Arash Rezazadeh, additional, Carthon, Bradley, additional, Loidl, Wolfgang, additional, Franke, Fabio, additional, Girotto, Gustavo, additional, Alimohamed, Nimira, additional, Macfarlane, Robyn, additional, Pappot, Helle, additional, Niegisch, Guenter, additional, Mavroudis, Dimitrios, additional, Sella, Avishay, additional, Porta, Camillo, additional, Ebara, Shin, additional, Nakamura, Motonobu, additional, Obara, Wataru, additional, Okuno, Norihiko, additional, Shinohara, Nobuo, additional, Sugimoto, Mikio, additional, Suzuki, Akitaka, additional, Tokuda, Noriaki, additional, Uemura, Hiroji, additional, Yamaguchi, Akito, additional, Ramirez, Francisco, additional, Rozanowski, Pawel, additional, Wiechno, Pawel, additional, Keam, Bhumsuk, additional, Kislov, Nikolay, additional, Plaksin, Denis, additional, Cicin, Irfan, additional, Kumar, Satish, additional, Galsky, Matthew D., additional, Petrylak, Daniel P., additional, Rosales, Joseph, additional, Vaishampayan, Ulka, additional, Culine, Stephane, additional, Papandreou, Christos, additional, Nara, Taketoshi, additional, Erman, Mustafa, additional, Kreiger, Laurence, additional, Janoski, Juliana, additional, Rosa, Diogo, additional, Siqueira, Mariana, additional, Canil, Christina, additional, Sengelov, Lisa, additional, Tourani, Jean-Marc, additional, Arai, Gaku, additional, Hashine, Katsuyoshi, additional, Kawakita, Mutsushi, additional, Nakaigawa, Noboru, additional, Nomi, Hayahito, additional, Shiina, Hiroaki, additional, Suzuki, Hiroyoshi, additional, Yonese, Junji, additional, Kuri, Roberto, additional, Macedo, Eleazar, additional, Rivera, Samuel, additional, Villalobos Prieto, Alberto, additional, Polakiewicz-Gilowska, Anna, additional, Zaucha, Renata, additional, Lopes, Fabio, additional, Ponomarev, Roman, additional, Pomerantz, Mark, additional, Shariat, Shahrokh, additional, Luk, Cynthia, additional, and Lesniewski-Kmak, Krzysztof, additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results